Gt Biopharma Inc stock is traded at $4.54, with a volume of 73,378. It is down -6.20% in the last 24 hours and down -28.73% over the past month. GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
Previous Close:
$4.84
Open:
$4.78
24h Volume:
73,378
Relative Volume:
1.05
Market Cap:
$8.19M
Revenue:
$63,000
Net Income/Loss:
-$47.73M
P/E Ratio:
-
EPS:
-$14.40
Net Cash Flow:
-$13.18M
1W Performance:
-14.66%
1M Performance:
-28.73%
6M Performance:
-54.90%
1Y Performance:
-67.19%
1-Day Range:
$0.00$0.00
1-Week Range:
$4.38$5.40
52-Week Range:
$4.38$28.75
Gt Biopharma Inc Stock (GTBP) Company Profile
Name
Gt Biopharma IncSector
HealthcareIndustry
BiotechnologyPhone
(800) 304-9888Address
505 MONTGOMERY STREET, SAN FRANCISCO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS